{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:47:10Z","timestamp":1764841630987},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s12016-010-8206-2","type":"journal-article","created":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T04:11:26Z","timestamp":1275279086000},"page":"89-101","source":"Crossref","is-referenced-by-count":12,"title":["Intranasal Steroids in the Treatment of Allergy-Induced Rhinorrhea"],"prefix":"10.1007","volume":"41","author":[{"given":"Robert A.","family":"Nathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"issue":"pt 2","key":"8206_CR1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1081-1206(10)63155-9","volume":"81","author":"MS Dykewicz","year":"1998","unstructured":"Dykewicz MS, Fineman S, Skoner DP et al (1998) Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology. Ann Allergy Asthma Immunol 81(pt 2):478\u2013518","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5 Suppl","key":"8206_CR2","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","volume":"108","author":"J Bousquet","year":"2001","unstructured":"Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Workshop Group; World Health Organization et al (2001) Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 108(5 Suppl):S147\u2013S334","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 86","key":"8206_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J (2008) Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 63(Suppl 86):8\u2013160","journal-title":"Allergy"},{"key":"8206_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-3038.2006.00424.x","volume":"17","author":"S Miri","year":"2006","unstructured":"Miri S, Farid R, Akbari H, Amin R (2006) Prevalence of allergic rhinitis and nasal smear eosinophilia in 11- to 15-yr-old children in Shiraz. Pediatr Allergy Immunol 17:519\u2013523","journal-title":"Pediatr Allergy Immunol"},{"issue":"Suppl 85","key":"8206_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1398-9995.2007.01549.x","volume":"62","author":"GW Canonica","year":"2007","unstructured":"Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchouw JC (2007) A survey of the burden of allergic rhinitis in Europe. Allergy 62(Suppl 85):17\u201325","journal-title":"Allergy"},{"key":"8206_CR6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00151829-200504060-00007","volume":"4","author":"A Shedden","year":"2005","unstructured":"Shedden A (2005) Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Findings from a large online survey. Treat Respir Med 4:439\u2013446","journal-title":"Treat Respir Med"},{"key":"8206_CR7","unstructured":"Attitudes about allergies (2008) key findings. Schering Corporation\/Merck & Co"},{"key":"8206_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1398-9995.2006.01057.x","volume":"61","author":"H Hoecke Van","year":"2006","unstructured":"Van Hoecke H, Vastesaeger N, DeWulf L, Sys L, van Cauwenberge P (2006) Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy 61:705\u2013711","journal-title":"Allergy"},{"key":"8206_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","volume":"55","author":"P Cauwenberge van","year":"2000","unstructured":"van Cauwenberge P, Bachert C, Passalacqua G, European Academy of Allergology and Clinical Immunology et al (2000) Consensus statement on the treatment of allergic rhinitis. Allergy 55:116\u2013134","journal-title":"Allergy"},{"key":"8206_CR10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","volume":"108","author":"DP Skoner","year":"2001","unstructured":"Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108:S2\u2013S8","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.amjoto.2008.06.015","volume":"30","author":"S Canakcioglu","year":"2009","unstructured":"Canakcioglu S, Tahamiler R, Saritzali G et al (2009) Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year study. Am J Otolaryngol 30:312\u2013317","journal-title":"Am J Otolaryngol"},{"key":"8206_CR12","first-page":"E397","volume":"12","author":"A Abuabara","year":"2007","unstructured":"Abuabara A (2007) Cerebrospinal fluid rhinorrhea: diagnosis and management. Med Oral Patol Oral Cir Bucal 12:E397\u2013E400","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"8206_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2222.2007.02888.x","volume":"38","author":"GK Scadding","year":"2008","unstructured":"Scadding GK, Durham SR, Mirakian R, British Society for Allergy and Clinical Immunology et al (2008) BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 38:19\u201342","journal-title":"Clin Exp Allergy"},{"key":"8206_CR14","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1016\/j.jaci.2004.12.016","volume":"115","author":"A Akerlund","year":"2005","unstructured":"Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N (2005) Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. J Allergy Clin Immunol 115:S460\u2013S482","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1067\/mai.2002.124657","volume":"109","author":"F Horak","year":"2002","unstructured":"Horak F, St\u00fcbner UP, Zieglmayer R, Ing D, Harris AG (2002) Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 109:956\u2013961","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2222.2005.02274.x","volume":"35","author":"J Bousquet","year":"2005","unstructured":"Bousquet J, Annesi-Maesano I, Carat F et al (2005) Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 35:728\u2013732","journal-title":"Clin Exp Allergy"},{"key":"8206_CR17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1081-1206(10)61826-1","volume":"90","author":"S Gawchik","year":"2003","unstructured":"Gawchik S, Goldstein S, Prenner B, John A (2003) Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol 90:416\u2013421","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR18","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1378\/chest.129.1_suppl.63S","volume":"129","author":"MR Pratter","year":"2006","unstructured":"Pratter MR (2006) Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 129:63S\u201371S","journal-title":"Chest"},{"key":"8206_CR19","first-page":"86","volume":"46","author":"A Sanu","year":"2008","unstructured":"Sanu A, Eccles R (2008) Postnasal drip syndrome. Two hundred years of controversy between UK and USA. Rhinology 46:86\u201391","journal-title":"Rhinology"},{"key":"8206_CR20","unstructured":"Schulman, Ronca, and Bucuvalas, Inc. (SRBI). Allergies in America: A Landmark Survey of Nasal Allergy Sufferers. Executive Summary. Available at http:\/\/www.myallergiesinamerica.com\/ . Accessed 8 December, 2009)"},{"key":"8206_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clinthera.2007.02.007","volume":"29","author":"AA Long","year":"2007","unstructured":"Long AA (2007) Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis. Clin Ther 29:342\u2013351","journal-title":"Clin Ther"},{"key":"8206_CR22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3346\/jkms.2001.16.6.697","volume":"16","author":"Y-G Min","year":"2001","unstructured":"Min Y-G, Choi B-Y, Kwon S-K et al (2001) Multicenter study on the prevalence of perennial allergic rhinitis and allergy-associated disorders. J Korean Med Sci 16:697\u2013701","journal-title":"J Korean Med Sci"},{"key":"8206_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/108854198778557962","volume":"19","author":"HB Kaiser","year":"1998","unstructured":"Kaiser HB, Findlay SR, Georgitis JW et al (1998) The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Allergy and Asthma Proc 19:23\u201329","journal-title":"Allergy and Asthma Proc"},{"key":"8206_CR24","doi-asserted-by":"crossref","first-page":"S763","DOI":"10.1016\/S0091-6749(97)70125-8","volume":"99","author":"JN Baraniuk","year":"1997","unstructured":"Baraniuk JN (1997) Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99:S763\u2013S772","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl I","key":"8206_CR25","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2466-6-S1-S5","volume":"6","author":"PK Jeffery","year":"2006","unstructured":"Jeffery PK, Haahtela T (2006) Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 6(Suppl I):S5\u2013S17","journal-title":"BMC Pulm Med"},{"key":"8206_CR26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1358\/dot.2003.39.6.799450","volume":"39","author":"I Izquierdo","year":"2003","unstructured":"Izquierdo I, Merlos M, Garc\u00eda-Rafanell J (2003) Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. Drugs Today 39:451\u2013468","journal-title":"Drugs Today"},{"issue":"Suppl 3","key":"8206_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1081-1206(10)61653-5","volume":"90","author":"WE Berger","year":"2003","unstructured":"Berger WE (2003) Overview of allergic rhinitis. Ann Allergy Asthma Immunol 90(Suppl 3):7\u201312","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 75","key":"8206_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1398-9995.57.s75.5.x","volume":"57","author":"F Horak","year":"2002","unstructured":"Horak F (2002) Impact and modulation of nasal obstruction. Allergy 57(Suppl 75):25\u201328","journal-title":"Allergy"},{"key":"8206_CR29","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1067\/mai.2001.115561","volume":"108","author":"N Mygind","year":"2001","unstructured":"Mygind N, Nielsen LP, Hoffman HJ et al (2001) Mode of action of intranasal corticosteroids. J Allergy Clin Immunol 108:S16\u2013S25","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1398-9995.2002.1r3542.x","volume":"57","author":"C Bachert","year":"2002","unstructured":"Bachert C (2002) The role of histamine in allergic disease: re-appraisal of its inflammatory potential. Allergy 57:287\u2013296","journal-title":"Allergy"},{"key":"8206_CR31","first-page":"537","volume":"60","author":"M Okuda","year":"1988","unstructured":"Okuda M, Watase T, Mezawa A, Liu C-M (1988) The role of leukotriene D4 in allergic rhinitis. Ann Allergy 60:537\u2013540","journal-title":"Ann Allergy"},{"key":"8206_CR32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.clinthera.2008.04.011","volume":"30","author":"RA Nathan","year":"2008","unstructured":"Nathan RA (2008) The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis. Clin Ther 30:573\u2013586","journal-title":"Clin Ther"},{"key":"8206_CR33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1067\/mai.2001.111236","volume":"107","author":"T Fujikura","year":"2001","unstructured":"Fujikura T, Shimosawa T, Yakuo I (2001) Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. J Allergy Clin Immunol 107:123\u2013128","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1081-1206(10)63141-9","volume":"81","author":"M Frieri","year":"1998","unstructured":"Frieri M, Therattil J, Chavarria V et al (1998) Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 81:431\u2013437","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1081-1206(10)62491-X","volume":"86","author":"G Ciprandi","year":"2001","unstructured":"Ciprandi G, Tosca MA, Passalacqua G, Canonica GW (2001) Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge. Ann Allergy Asthma Immunol 86:433\u2013438","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR36","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1034\/j.1398-9995.1999.00200.x","volume":"54","author":"C Ortolani","year":"1999","unstructured":"Ortolani C, Foresi A, Di Lorenzo G et al (1999) A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian study group. Allergy 54:1173\u20131180","journal-title":"Allergy"},{"key":"8206_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000236609","volume":"103","author":"A Konno","year":"1994","unstructured":"Konno A, Yamakoshi T, Terada N, Fujita Y (1994) Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy. Int Arch Allergy Immunol 103:79\u201387","journal-title":"Int Arch Allergy Immunol"},{"key":"8206_CR38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0091-6749(97)70144-1","volume":"100","author":"SP Umland","year":"1997","unstructured":"Umland SP, Nahrebne K, Razac S et al (1997) The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-\u03b3 production by cultured primary CD4+ T cells. J Allergy Clin Immunol 100:511\u2013519","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0091-6749(93)90015-8","volume":"92","author":"RM Naclerio","year":"1993","unstructured":"Naclerio RM, Adkinson NF, Creticos PS, Baroody FM, Hamilton RG, Norman PS (1993) Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol 92:717\u2013721","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR40","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1365-2222.1999.00665.x","volume":"29","author":"AF Holm","year":"1999","unstructured":"Holm AF, Godthelp T, Fokkens WJ et al (1999) Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis. Clin Exp Allergy 29:1356\u20131366","journal-title":"Clin Exp Allergy"},{"key":"8206_CR41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(88)90198-4","volume":"81","author":"R Bascom","year":"1988","unstructured":"Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM (1988) Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 81:580\u2013589","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2222.1994.tb02724.x","volume":"24","author":"S Rak","year":"1994","unstructured":"Rak S, Jacobson MR, Sudderick RM et al (1994) Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 24:930\u2013939","journal-title":"Clin Exp Allergy"},{"key":"8206_CR43","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bmj.317.7173.1624","volume":"317","author":"JM Weiner","year":"1998","unstructured":"Weiner JM, Abramson MJ, Puy RM (1998) Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317:1624\u20131629","journal-title":"BMJ"},{"key":"8206_CR44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1081-1206(10)62085-6","volume":"89","author":"A Y\u00e1\u00f1ez","year":"2002","unstructured":"Y\u00e1\u00f1ez A, Rodrigo GJ (2002) Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 89:479\u2013484","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.otohns.2007.10.027","volume":"138","author":"R Naclerio","year":"2008","unstructured":"Naclerio R (2008) Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg 138:129\u2013139","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8206_CR46","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2008.01808.x","volume":"63","author":"M Penagos","year":"2008","unstructured":"Penagos M, Compalati E, Tarantini F, Baena-Cagnani CE, Passalacqua G, Canonica GW (2008) Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy 63:1280\u20131291","journal-title":"Allergy"},{"key":"8206_CR47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1081-1206(10)60452-8","volume":"100","author":"R Anolik","year":"2008","unstructured":"Anolik R, Mometasone Furoate Nasal Spray With Loratadine Study Group (2008) Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 100:264\u2013271","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1034\/j.1398-9995.1999.00713.x","volume":"54","author":"RB Berkowitz","year":"1999","unstructured":"Berkowitz RB, Bernstein DI, LaForce C et al (1999) Onset of action of mometasone furoate nasal spray (Nasonex\u00ae) in seasonal allergic rhinitis. Allergy 54:64\u201369","journal-title":"Allergy"},{"key":"8206_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1081-1206(10)60624-2","volume":"99","author":"P Chervinsky","year":"2007","unstructured":"Chervinsky P, Kunjibettu S, Miller DL et al (2007) Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol 99:69\u201376","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2222.2004.01877.x","volume":"34","author":"G Lorenzo Di","year":"2004","unstructured":"Di Lorenzo G, Pacor ML, Pellitteri ME et al (2004) Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 34:259\u2013267","journal-title":"Clin Exp Allergy"},{"key":"8206_CR51","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1398-9995.2007.01522.x","volume":"62","author":"WJ Fokkens","year":"2007","unstructured":"Fokkens WJ, Jogi R, Reinartz S et al (2007) Once daily fluticasone furoate nasal spray is effective in seasonal allergy rhinitis caused by grass pollen. Allergy 62:1078\u20131084","journal-title":"Allergy"},{"key":"8206_CR52","first-page":"569","volume":"51","author":"JR Hebert","year":"1996","unstructured":"Hebert JR, Nolop K, Lutsky BN (1996) Once-daily mometasone furoate aqueous nasal spray (Nasonex\u2122) in seasonal allergic rhinitis: an active- and placebo-controlled study. Allergy 51:569\u2013576","journal-title":"Allergy"},{"key":"8206_CR53","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2007.02.022","volume":"119","author":"HB Kaiser","year":"2007","unstructured":"Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE (2007) Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 119:1430\u20131437","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR54","first-page":"145","volume":"38","author":"CF LaForce","year":"1994","unstructured":"LaForce CF, Dockhorn RJ, Findlay SR et al (1994) Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. J Fam Pract 38:145\u2013152","journal-title":"J Fam Pract"},{"key":"8206_CR55","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1081-1206(10)63030-X","volume":"79","author":"M Mandl","year":"1997","unstructured":"Mandl M, Nolop K, Lutsky BN, 194-079 Study Group (1997) Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. Ann Allergy Asthma Immunol 79:370\u2013378","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1081-1206(10)60693-X","volume":"98","author":"EO Meltzer","year":"2007","unstructured":"Meltzer EO, Kunjibettu S, Hall N et al (2007) Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 98:175\u2013181","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1081-1206(10)60477-2","volume":"100","author":"RA Nathan","year":"2008","unstructured":"Nathan RA, Berger W, Yang W et al (2008) Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 100:497\u2013505","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR58","doi-asserted-by":"crossref","unstructured":"Prenner B, Lanier BQ, Bernstein D, Shekar T, Teper A. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2010 (in press)","DOI":"10.1016\/j.jaci.2010.03.004"},{"key":"8206_CR59","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2006.07.050","volume":"118","author":"PH Ratner","year":"2006","unstructured":"Ratner PH, Wingertzahn MA, van Bavel JH et al (2006) Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 118:1142\u20131148","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR60","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2222.1995.tb00011.x","volume":"25","author":"GK Scadding","year":"1995","unstructured":"Scadding GK, Lund VJ, Jacques LA, Richards DH (1995) A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 25:737\u2013743","journal-title":"Clin Exp Allergy"},{"key":"8206_CR61","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/0091-6749(93)90317-9","volume":"91","author":"A As van","year":"1993","unstructured":"van As A, Bronsky EA, Dockhorn RJ et al (1993) Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone dipropionate. J Allergy Clin Immunol 91:1146\u20131154","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2500\/aap.2008.29.3126","volume":"29","author":"M Vasar","year":"2008","unstructured":"Vasar M, Houle P-A, Douglass J-A et al (2008) Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults\/adolescents. Allergy Asthma Proc 29:313\u2013321","journal-title":"Allergy Asthma Proc"},{"key":"8206_CR63","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0091-6749(95)70217-2","volume":"95","author":"HB Kaiser","year":"1995","unstructured":"Kaiser HB, Findlay SR, Georgitis JW et al (1995) Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. J Allergy Clin Immunol 95:1128\u20131132","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR64","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","volume":"122","author":"DV Wallace","year":"2008","unstructured":"Wallace DV, Dykewicz MS, Bernstein DI, Joint Task Force on Practice; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology et al (2008) The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122:S1\u201384","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR65","unstructured":"Atrovent Nasal spray 0.03% (ipratropium bromide) package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2007"},{"key":"8206_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)62620-8","volume":"83","author":"H Milgrom","year":"1999","unstructured":"Milgrom H, Biondi R, Georgitis JW et al (1999) Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol 83:105\u2013111","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0091-6749(92)90078-G","volume":"90","author":"EO Meltzer","year":"1992","unstructured":"Meltzer EO, Orgel HA, Bronsky EA et al (1992) Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 90:242\u2013249","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR68","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0091-6749(92)90125-L","volume":"90","author":"JW Georgitis","year":"1992","unstructured":"Georgitis JW (1992) The anticholinergic treatment of allergic perennial rhinitis. J Allergy Clin Immunol 90:1071\u20131076","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1081-1206(10)63284-X","volume":"82","author":"R Dockhorn","year":"1999","unstructured":"Dockhorn R, Aaronson D, Bronsky E et al (1999) Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 82:349\u2013359","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR70","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1081-1206(10)61339-7","volume":"96","author":"GJ Rodrigo","year":"2006","unstructured":"Rodrigo GJ, Ya\u00f1ez A (2006) The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol 96:779\u2013786","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03256639","volume":"2","author":"LP Nielsen","year":"2003","unstructured":"Nielsen LP, Dahl R (2003) Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. Am J Respir Med 2:55\u201365","journal-title":"Am J Respir Med"},{"key":"8206_CR72","first-page":"89","volume":"4","author":"DA Stempel","year":"1998","unstructured":"Stempel DA, Thomas M (1998) Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines. Am J Man Care 4:89\u201396","journal-title":"Am J Man Care"},{"key":"8206_CR73","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1081-1206(10)61847-9","volume":"90","author":"PH Ratner","year":"2003","unstructured":"Ratner PH, Howland WC III, Arastu R et al (2003) Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol 90:536\u2013542","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1081-1206(10)61349-X","volume":"96","author":"BG Martin","year":"2006","unstructured":"Martin BG, Andrews CP, van Bavel JH et al (2006) Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol 96:851\u2013857","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8206_CR75","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1398-9995.2005.00906.x","volume":"61","author":"K Parameswaran","year":"2006","unstructured":"Parameswaran K, Fanat A, O\u2019Byrne PM (2006) Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. Allergy 61:731\u2013736","journal-title":"Allergy"},{"key":"8206_CR76","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(96)80151-5","volume":"97","author":"DI Bernstein","year":"1996","unstructured":"Bernstein DI, Creticos PS, Busse WW et al (1996) Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 97:749\u2013755","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR77","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaci.2005.09.047","volume":"117","author":"J Bousquet","year":"2006","unstructured":"Bousquet J, Neukirch F, Bousquet PJ et al (2006) Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117:158\u2013162","journal-title":"J Allergy Clin Immunol"},{"key":"8206_CR78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcrj.2005.11.002","volume":"15","author":"D Price","year":"2006","unstructured":"Price D, Bond C, Bouchard J et al (2006) International Primary Care Respiratory Group (ICPRG) Guidelines: management of allergic rhinitis. Prim Care Respir J 15:58\u201370","journal-title":"Prim Care Respir J"},{"key":"8206_CR79","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2500\/108854101778249267","volume":"22","author":"MA Kaliner","year":"2001","unstructured":"Kaliner MA (2001) Physician prescribing practices: the role of patient preference in the selection of nasal steroids. Allergy Asthma Proc 22:S17\u2013S22","journal-title":"Allergy Asthma Proc"},{"key":"8206_CR80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1034\/j.1398-9995.2003.00076.x","volume":"58","author":"J Bousquet","year":"2003","unstructured":"Bousquet J, Lund VJ, van Cauwenberge P et al (2003) Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 58:733\u2013741","journal-title":"Allergy"},{"key":"8206_CR81","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1034\/j.1398-9995.2003.00256.x","volume":"58","author":"WJ Fokkens","year":"2003","unstructured":"Fokkens WJ (2003) Nasal corticosteroids, first choice in moderate to several allergic rhinitis. What prevents general practitioners from using them? Allergy 58:724\u2013726","journal-title":"Allergy"},{"key":"8206_CR82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00002018-200730040-00004","volume":"30","author":"M Zitt","year":"2007","unstructured":"Zitt M, Kosoglou T, Hubbell J (2007) Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf 30:317\u2013326","journal-title":"Drug Saf"},{"key":"8206_CR83","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1398-9995.2007.01521.x","volume":"62","author":"A Rosenblut","year":"2007","unstructured":"Rosenblut A, Bardin PG, Muller B et al (2007) Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 62:1071\u20131077","journal-title":"Allergy"},{"key":"8206_CR84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amjoto.2007.11.004","volume":"29","author":"P Demoly","year":"2008","unstructured":"Demoly P (2008) Safety of intranasal corticosteroids in acute rhinosinusitis. Am J Otolaryngol 29:403\u2013413","journal-title":"Am J Otolaryngol"},{"key":"8206_CR85","unstructured":"Omnaris (ciclesonide) package insert (2007) Florham Park, NJ: Altana Pharma, US Inc."},{"key":"8206_CR86","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2165\/00002018-200326120-00003","volume":"26","author":"RJ Salib","year":"2003","unstructured":"Salib RJ, Howarth PH (2003) Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 26:863\u2013893","journal-title":"Drug Saf"},{"key":"8206_CR87","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/bmj.320.7243.1184","volume":"320","author":"RD Mann","year":"2000","unstructured":"Mann RD, Pearce GL, Dunn N, Shakir S (2000) Sedation with \u201cnon-sedating\u201d antihistamines: four prescription-event monitoring studies in general practice. BMJ 320:1184\u20131187","journal-title":"BMJ"},{"key":"8206_CR88","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2165\/00002018-200629100-00007","volume":"29","author":"D Layton","year":"2006","unstructured":"Layton D, Wilton L, Boshier A, Cornelius V, Harris S, Shakir SA (2006) Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. Drug Saf 29:897\u2013909","journal-title":"Drug Saf"},{"key":"8206_CR89","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00063030-200115070-00004","volume":"15","author":"SP Galant","year":"2001","unstructured":"Galant SP, Wilkinson R (2001) Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child. What are the options? BioDrugs 15:453\u2013463","journal-title":"BioDrugs"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8206-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8206-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:47Z","timestamp":1559440127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8206-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["8206"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8206-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}